TWO SIGMA INVESTMENTS, LP - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$11,000
-75.6%
16,843
-72.1%
0.00%
Q2 2022$45,000
+28.6%
60,383
+224.5%
0.00%
Q1 2022$35,000
-97.9%
18,610
-94.2%
0.00%
-100.0%
Q1 2021$1,649,000
+111.1%
323,362
+103.6%
0.00%
+100.0%
Q4 2020$781,000158,8140.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders